insights_auto
Zašto je NVSEF pao 3,76%?
Istražite detaljnijechevron_right
NVSEF:OTCMKTS
Novartis
137,80 USD
arrow_downward
−3,76%(−5,38) 1D
13. lis, 16:00:00 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za NVSEF...
Otvori
140,73 USD
Najviša
140,73 USD
Najniža
137,80 USD
Trž. kap.
289,63 mlr.
Prosj. kol.
30,95 tis.
Količina
854,00
52-tjed. najviša
171,29 USD
52-tjed. najniža
120,00 USD
Beta
0,40
Dionice u optjecaju
2,03 mlr.
Broj djelatnika
75 tis.
Otvori
140,73 USD
Najviša
140,73 USD
Najniža
137,80 USD
Trž. kap.
289,63 mlr.
Prosj. kol.
30,95 tis.
Količina
854,00
52-tjed. najviša
171,29 USD
52-tjed. najniža
120,00 USD
Beta
0,40
Dionice u optjecaju
2,03 mlr.
Broj djelatnika
75 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
ad-hoc-news.de
·
prije 16 sati
Morgan Stanley cuts target for Novartis stock to USD 156.00
ad-hoc-news.de
·
prije 21 sat
Novartis stock pre-market at EUR 128.74
ad-hoc-news.de
·
prije 23 sata
DKSH expands Novartis partnership as seven analysts track DKSH stock
marketscreener.com
·
prije 1 dan
Swiss Blue-chip Index Starts Week Upbeat; Roche, Novartis Shares Gain
Profil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Novartis – informacije
Glavni izvršni direktorVasant Narasimhan
Zaposlenici75,3 tis.
Osnovano7. ožu 1996.
SjedišteBasel, Basel-grad, Švicarska
Sektor-
Web-lokacijanovartis.com